Henry Schein, Inc. (NASDAQ:HSIC) Expected to Earn Q3 2024 Earnings of $1.13 Per Share

Henry Schein, Inc. (NASDAQ:HSICFree Report) – Barrington Research cut their Q3 2024 EPS estimates for shares of Henry Schein in a report released on Wednesday, August 7th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings per share of $1.13 for the quarter, down from their previous forecast of $1.33. Barrington Research has a “Outperform” rating and a $82.00 price target on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $5.16 per share. Barrington Research also issued estimates for Henry Schein’s Q4 2024 earnings at $1.27 EPS.

A number of other research analysts have also recently issued reports on HSIC. UBS Group cut their price target on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Piper Sandler reissued an “overweight” rating and set a $86.00 price target on shares of Henry Schein in a research note on Friday, June 21st. Evercore ISI lowered their price target on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a report on Wednesday. Finally, Robert W. Baird reduced their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $77.90.

Get Our Latest Research Report on HSIC

Henry Schein Trading Up 1.1 %

Shares of HSIC opened at $68.94 on Friday. The stock has a fifty day moving average price of $67.73 and a two-hundred day moving average price of $71.55. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.02 and a current ratio of 1.75. The company has a market cap of $8.83 billion, a price-to-earnings ratio of 23.29, a PEG ratio of 1.80 and a beta of 0.87. Henry Schein has a 52-week low of $60.01 and a 52-week high of $82.63.

Henry Schein (NASDAQ:HSICGet Free Report) last posted its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The company had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. Henry Schein’s quarterly revenue was up .0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.31 earnings per share.

Institutional Investors Weigh In On Henry Schein

A number of institutional investors have recently made changes to their positions in HSIC. Swedbank AB bought a new position in Henry Schein during the first quarter worth about $215,998,000. Boston Partners raised its position in shares of Henry Schein by 144.1% in the 4th quarter. Boston Partners now owns 2,637,429 shares of the company’s stock valued at $199,393,000 after acquiring an additional 1,556,831 shares during the period. Norges Bank bought a new position in Henry Schein during the 4th quarter worth approximately $111,715,000. Nuance Investments LLC acquired a new position in Henry Schein during the fourth quarter valued at approximately $103,446,000. Finally, Thompson Siegel & Walmsley LLC bought a new stake in Henry Schein in the second quarter valued at approximately $46,683,000. 96.62% of the stock is owned by institutional investors and hedge funds.

About Henry Schein

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Stories

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.